US generic business gained 16.28 percent to Rs 855.7 crore in the December quarter YoY while sales for the formulation business in India rose 15.39 percent to Rs 667.5 crore YoY.from Moneycontrol Latest News http://bit.ly/2IbUvO9
Glenmark Pharma plunges 9% after Q3 profit misses analyst estimates
US generic business gained 16.28 percent to Rs 855.7 crore in the December quarter YoY while sales for the formulation business in India rose 15.39 percent to Rs 667.5 crore YoY.from Moneycontrol Latest News http://bit.ly/2IbUvO9
0 comments:
Post a Comment